Ann K Rosenthal1,2. 1. Department of Medicine, Division of Rheumatology, Medical College of Wisconsin. 2. Department of Medicine, Zablocki VA Medical Center, Milwaukee, Wisconsin, USA.
Abstract
PURPOSE OF REVIEW: Basic calcium phosphate (BCP) crystals are associated with two important musculoskeletal syndromes. Deposition of BCP crystals in tendons, bursae, and other soft tissues around joints causes calcific periarthritis, whereas intra-articular BCP crystals contribute to osteoarthritis and cause the highly destructive arthritis known as Milwaukee Shoulder Syndrome. The epidemiology and natural history of these syndromes are poorly understood, and because the pathogenesis remains unclear, few targeted therapies are available. I will review new developments in this field. RECENT FINDINGS: I will discuss a case collection of calcific periarthritis of the hip, and evidence-based management strategies for shoulder calcific periarthritis that might be applied to calcific periarthritis at other locations. I will summarize several recent articles addressing mechanisms of crystal formation and identifying pathways through which BCP crystals produce tissue damage and explore some newly identified risk factors for pathologic mineralization. SUMMARY: We are making slow, but steady progress in understanding the clinical presentation of calcific periarthritis in sites other than the shoulder. A growing appreciation of the mechanisms through which BCP crystals mediate tissue damage should lead to the development of novel management strategies for these common musculoskeletal syndromes.
PURPOSE OF REVIEW: Basic calcium phosphate (BCP) crystals are associated with two important musculoskeletal syndromes. Deposition of BCP crystals in tendons, bursae, and other soft tissues around joints causes calcific periarthritis, whereas intra-articular BCP crystals contribute to osteoarthritis and cause the highly destructive arthritis known as Milwaukee Shoulder Syndrome. The epidemiology and natural history of these syndromes are poorly understood, and because the pathogenesis remains unclear, few targeted therapies are available. I will review new developments in this field. RECENT FINDINGS: I will discuss a case collection of calcific periarthritis of the hip, and evidence-based management strategies for shoulder calcific periarthritis that might be applied to calcific periarthritis at other locations. I will summarize several recent articles addressing mechanisms of crystal formation and identifying pathways through which BCP crystals produce tissue damage and explore some newly identified risk factors for pathologic mineralization. SUMMARY: We are making slow, but steady progress in understanding the clinical presentation of calcific periarthritis in sites other than the shoulder. A growing appreciation of the mechanisms through which BCP crystals mediate tissue damage should lead to the development of novel management strategies for these common musculoskeletal syndromes.
Authors: Núria Guañabens; Steven Mumm; Ingrid Möller; Eva González-Roca; Pilar Peris; Jennifer L Demertzis; Michael P Whyte Journal: J Bone Miner Res Date: 2014-04 Impact factor: 6.741
Authors: Viola Pomozi; Christopher Brampton; Koen van de Wetering; Janna Zoll; Bianca Calio; Kevin Pham; Jesse B Owens; Joel Marh; Stefan Moisyadi; András Váradi; Ludovic Martin; Carolin Bauer; Jeanette Erdmann; Zouhair Aherrahrou; Olivier Le Saux Journal: Am J Pathol Date: 2017-04-14 Impact factor: 4.307
Authors: Sofia Cavaco; Carla S B Viegas; Marta S Rafael; Acácio Ramos; Joana Magalhães; Francisco J Blanco; Cees Vermeer; Dina C Simes Journal: Cell Mol Life Sci Date: 2015-09-04 Impact factor: 9.261
Authors: Carlos Fernández-Palomeque; Andres Grau; Joan Perelló; Pilar Sanchis; Bernat Isern; Rafel M Prieto; Antonia Costa-Bauzá; Onofre J Caldés; Oriol Bonnin; Ana Garcia-Raja; Armando Bethencourt; Felix Grases Journal: PLoS One Date: 2015-08-31 Impact factor: 3.240
Authors: Vivien M Hsu; Eszter Kozák; Qiaoli Li; Márta Bocskai; Naomi Schlesinger; Ann Rosenthal; Scott T McClure; László Kovács; László Bálint; Szilvia Szamosi; Gabriella Szücs; Mary Carns; Kathleen Aren; Isaac Goldberg; András Váradi; John Varga Journal: Rheumatology (Oxford) Date: 2022-03-02 Impact factor: 7.046